Trial
NCT00671528
Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4)
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Organon and Co
Collaborators
—
Condition
Dermatitis, Atopic
Intervention
Cream (betamethasone diproprionate, clotrimazole, and gentamicin sulfate)
Why stopped
terminated early due to lack of recruitment \[only 3 of 207 subjects were enrolled\]
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-09